Cargando…

Targeting the HGF/MET Axis in Cancer Therapy: Challenges in Resistance and Opportunities for Improvement

Among hundreds of thousands of signal receptors contributing to oncogenic activation, tumorigenesis, and metastasis, the hepatocyte growth factor (HGF) receptor – also called tyrosine kinase MET – is a promising target in cancer therapy as its axis is involved in several different cancer types. It i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xing, Li, Enliang, Shen, Hang, Wang, Xun, Tang, Tianyu, Zhang, Xiaozhen, Xu, Jian, Tang, Zengwei, Guo, Chengxiang, Bai, Xueli, Liang, Tingbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218174/ https://www.ncbi.nlm.nih.gov/pubmed/32435640 http://dx.doi.org/10.3389/fcell.2020.00152

Ejemplares similares

The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
por: Wang, Haiyu, et al.
Publicado: (2020)

The AKT-independent MET–V-ATPase–MTOR axis suppresses liver cancer vaccination
por: Huang, Xing, et al.
Publicado: (2020)

HGF/c-Met Axis: The Advanced Development in Digestive System Cancer
por: Shao, Zhiwei, et al.
Publicado: (2020)

Crosstalk Mechanisms Between HGF/c-Met Axis and ncRNAs in Malignancy
por: Liu, Xin, et al.
Publicado: (2020)

Structural and Functional Insight Into the Glycosylation Impact Upon the HGF/c-Met Signaling Pathway
por: Hu, Xinyue, et al.
Publicado: (2020)

HGF and MET: From Brain Development to Neurological Disorders
por: Desole, Claudia, et al.
Publicado: (2021)

MACC1 Contributes to the Development of Osteosarcoma Through Regulation of the HGF/c-Met Pathway and Microtubule Stability
por: Wen, Jia, et al.
Publicado: (2020)

The Glypican-1/HGF/C-Met and Glypican-1/VEGF/VEGFR2 Ternary Complexes Regulate Hair Follicle Angiogenesis
por: Colin-Pierre, Charlie, et al.
Publicado: (2021)

VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy
por: Huang, Xing, et al.
Publicado: (2020)

Organoids: opportunities and challenges of cancer therapy
por: Jiang, Xianjie, et al.
Publicado: (2023)

The Long Non-coding RNA ZFAS1 Sponges miR-193a-3p to Modulate Hepatoblastoma Growth by Targeting RALY via HGF/c-Met Pathway
por: Cui, Xichun, et al.
Publicado: (2019)

Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges
por: Hao, Xiaopei, et al.
Publicado: (2021)

Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges
por: Sun, Guoqiang, et al.
Publicado: (2021)

Generation of Skin Organoids: Potential Opportunities and Challenges
por: Sun, Hui, et al.
Publicado: (2021)

Approaches to kidney replacement therapies—opportunities and challenges
por: Huang, Biao, et al.
Publicado: (2022)

Extracellular RNA in melanoma: Advances, challenges, and opportunities
por: Li, Zhouxiao, et al.
Publicado: (2023)

HGF/Met Axis in Heart Function and Cardioprotection
por: Gallo, Simona, et al.
Publicado: (2014)

Fibroadipogenic Progenitors Regulate the Basal Proliferation of Satellite Cells and Homeostasis of Pharyngeal Muscles via HGF Secretion
por: Kim, Eunhye, et al.
Publicado: (2022)

Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities
por: Prasuhn, Jannik, et al.
Publicado: (2021)

Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities
por: Claridge, Bethany, et al.
Publicado: (2021)

NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1
por: Zhang, Xiaozhen, et al.
Publicado: (2021)

Opportunities and Challenges of Small Molecule Induced Targeted Protein Degradation
por: He, Ming, et al.
Publicado: (2021)

Targeting the HGF-cMET Axis in Hepatocellular Carcinoma
por: Venepalli, Neeta K., et al.
Publicado: (2013)

Targeting HGF/c-MET Axis in Pancreatic Cancer
por: Pothula, Srinivasa P., et al.
Publicado: (2020)

Ferroptosis-associated circular RNAs: Opportunities and challenges in the diagnosis and treatment of cancer
por: Yang, Ruotong, et al.
Publicado: (2023)

Pluripotent Stem Cell Therapies for Parkinson Disease: Present Challenges and Future Opportunities
por: Kim, Tae Wan, et al.
Publicado: (2020)

Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current Opportunities
por: Yang, Jiani, et al.
Publicado: (2021)

Activated HGF-c-Met Axis in Head and Neck Cancer
por: Arnold, Levi, et al.
Publicado: (2017)

HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation
por: Spina, Anna, et al.
Publicado: (2015)

The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance
por: Huang, Xing, et al.
Publicado: (2019)

Rhodnius, Golden Oil, and Met: A History of Juvenile Hormone Research
por: Riddiford, Lynn M.
Publicado: (2020)

c-Met-integrin cooperation: Mechanisms, tumorigenic effects, and therapeutic relevance
por: Stanislovas, Justas, et al.
Publicado: (2022)

AI-Model for Identifying Pathologic Myopia Based on Deep Learning Algorithms of Myopic Maculopathy Classification and “Plus” Lesion Detection in Fundus Images
por: Lu, Li, et al.
Publicado: (2021)

MicroRNAs and Long Non-coding RNAs in c-Met-Regulated Cancers
por: Zhan, Hong, et al.
Publicado: (2020)

MET transcriptional regulator/serine peptidase inhibitor kunitz type 1 panel operating through HGF/c‐MET axis as a prognostic signature in pan‐cancer
por: Xiang, Yi, et al.
Publicado: (2021)

Fibroblast-derived Hgf controls recruitment and expansion of muscle during morphogenesis of the mammalian diaphragm
por: Sefton, Elizabeth M, et al.
Publicado: (2022)

Status of Agents Targeting the HGF/c-Met Axis in Lung Cancer
por: Miranda, Oshin, et al.
Publicado: (2018)

Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients
por: Tang, Zengwei, et al.
Publicado: (2022)

Correction: Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients
por: Tang, Zengwei, et al.
Publicado: (2022)

Split Cyclin-Dependent Kinase 4/6–Retinoblastoma 1 Axis in Pancreatic Cancer
por: Huang, Xing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_piuaavoompt6qvj72p8lvbhuft